Navigation Links
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
Date:10/26/2011

this therapy," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.

"This Phase 3 trial is one of two Phase 3 trials required by the FDA for approval," said Isaac Cohen, O.M.D., Chairman and Chief Executive Officer of Bionovo. "Menerba (MF101) has an enormous proven market and extraordinary market appeal due to its botanical origins and the safety and efficacy it demonstrated to date. We expect to have top-line data from this study in approximately 18 months."

About Menerba

Menerba is an oral drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause, which is manufactured from botanical sources. Menerba is an estrogen receptor beta (ER-b) selective drug, developed as an alternative to the products currently on the market which have been shown to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with activation of estrogen receptor alpha (ER-a) and that activation of estrogen receptor beta (ER-b) blocks the growth promoting effects on breast cancer cells. The active ingredients in Menerba are derived from botanicals with centuries of recorded safe, effective use in traditional Chinese medicine (TCM). Bionovo recognizes the opportunity to commercialize a product that would be as effective as hormone therapy, without the health risks. Menerba has completed a Phase 2 trial with positive results for efficacy and has been evaluated by an independent Data and Safety Monitoring Board and passed through a standard two-round examination for safety. Menerba also has been shown in animal studies to prevent the proliferation of breast cancer and to have a beneficial effect on osteoporosis, though this has not yet been studied in humans.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe a
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
2. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
3. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
6. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
7. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
8. Bionovo Announces 2010 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
10. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Radiology information ... is used to store, manipulate, and distribute patient ... patient tracking and scheduling system, result reporting, and ... with HIS and other databases improves the hospital ... patient scheduling, patient list management, radiology department workflow ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... and LYON, France , Dec. 19, ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ADOC) ... an ultra-rapid insulin, known as BioChaperone Lispro, for treatment ... BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology and ... and Adocia will develop BioChaperone Lispro with the goal ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... showed no consistent differences in bone mineral density ... Diskus 250/50 (fluticasone,propionate and salmeterol inhalation powder) and ... term use of Advair(R) in patients,with COPD, ... that data from a three-year study of patients ...
... BRANFORD, Conn., Oct. 29 CuraGen Corporation,(Nasdaq: ... announced today that Company executives will be holding ... on Monday, November 3, 2008,following the release of ... data from CuraGen,s Phase II clinical trial evaluating,CR011-vcMMAE ...
Cached Medicine Technology:Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 2Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 3CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
(Date:12/20/2014)... NY (PRWEB) December 20, 2014 The aftermath ... caused quite a stir, not only in Hollywood, but worldwide. ... December 18th , the ripples of that attack are starting ... very jobs at risk. But they are not the ... exposed could be in for some embarrassing times ahead, agents ...
(Date:12/20/2014)... 20, 2014 Parker & Sons, Inc. ... years of experience in contractor services announces reaching a ... for the homeowners of Arizona. Parker and Sons is ... contractor technicians that make customer service the number one ... Arizona and started with one service vehicle and has ...
(Date:12/19/2014)... 19, 2014 Sub Zero Ice Cream is ... blood drive Sunday the 28th from 2pm-6pm at the Expo ... Road in Sarasota, FL. , Inquiries regarding time slots and ... participating in the donating process, Sub Zero Ice Cream & ... custom ice cream. , About Sub Zero Ice Cream & ...
(Date:12/19/2014)... Canadian, OK (PRWEB) December 19, 2014 ... is home to Lake Eufaula, the state’s largest lake ... lovely lakeside town is home to a little more ... at 1:00 P.M. on Saturday, the 6th of December. ... made its way through downtown Eufaula on Main Street. ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- New research warns parents ... young lives at risk. Nearly half of teen drivers killed ... that were at least 11 years old and often lacked important ... Eighty-two percent of teen drivers killed in crashes were in ... six to 10 years old, 31 percent were in cars 11 ...
Breaking Medicine News(10 mins):Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Older Cars a Bad Choice for Younger Drivers 2
... The Second Harvest Food Bank of,Greater New Orleans ... to help feed local families, thanks to Smithfield Foods, ... initiative,led by celebrity cook Paula Deen., The tour,s ... to the,nation,s hungry families, including those in metropolitan New ...
... removal of a malignant tumor, the chance that cancer ... remains high. But new research from Tel Aviv University, ... those cancer cells from taking root again and ... A new study led by Prof. Shamgar Ben-Eliyahu, from ...
... kills more than 33,000 Americans per year, experts say ... say they,ve spotted several potential new drug targets for ... caused by a bacterial infection that enters the bloodstream, ... kills tens of thousands of Americans a year. , ...
... Over Serious, Ongoing Patient Care Problems Throughout ... System ... Vote - Overwhelming Yes, OAKLAND, Calif., Feb. 27 In the face of ... Health facilities in the Bay Area will vote this week,and next on whether to ...
... leave nation vulnerable to disease, bioterror and health, threats according to ... ... Public Health, WASHINGTON, Feb. 27 While natural disasters,the threat ... resources, the U.S. is facing a major public health,workforce crisis that could ...
... WASHINGTON, Feb. 27 The Association for,Professionals ... announced,that it has been selected by Blue ... a statewide effort to reduce healthcare-associated,infections (HAIs)., ... leading health organizations to expand,the Foundation,s innovative ...
Cached Medicine News:Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour To Feed New Orleans Families 2Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour To Feed New Orleans Families 3Health News:Stress and fear can affect cancer's recurrence 2Health News:Stress and fear can affect cancer's recurrence 3Health News:Research May Yield New Weapons Against Sepsis 2Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 2Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 3Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 3
... The ACCU-Beam® line of Surgical Microscope Accessories ... lenses, fiber optic cables, and fiberoptic retrofits. ... (US pat. no. 5,264,928) is the only ... 3CCD cameras on the same adaptor body. ...
... line of Surgical Microscope Accessories includes ... lenses, fiber optic cables, and fiberoptic ... Adaptor allows the surgeon to document ... either video or 35mm photography. Many ...
... The ACCU-Beam® line of Surgical Microscope ... objective lenses, fiber optic cables, and fiberoptic ... Adaptor (US pat. no. 5,264,928) is the ... and 3CCD cameras on the same adaptor ...
Inquire...
Medicine Products: